UCL matrix insight: Falsified medicines and the global public health

Related news and resources
79th World Health Assembly (WHA79): Reform of the global health architecture and the UN80 Initiative
On 21 May 2026, IFPMA delivered a statement on the reform of the global health architecture and the UN80 Initiative at the 79th session of the World Health Assembly. IFPMA believes a stronger global health architecture should foster innovation, strengthen health systems so innovations reach people, and forge partnerships to advance health globally. For the...
Read more79th World Health Assembly (WHA79): Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
On 21 May 2026, IFPMA published a statement on the follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, on the margins of the World Health Assembly. IFPMA welcomes WHO’s continued efforts to tackle one of the greatest health challenges of our lifetimes....
Read more79th World Health Assembly (WHA79): Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement
On 18 May 2026, IFPMA delivered a statement on the Open-Ended Intergovernmental Working Group on the WHO Pandemic Agreement at the 79th World Health Assembly in Geneva. The innovative pharmaceutical industry remains a critical partner in pandemic preparedness and response, with a strong track record of action during pandemics and Public Health Emergencies of International...
Read more

